SCHEMBL19081509

SCHEMBL19081509

c1ccc(-c2c3ccccc3c(-c3cccc(-c4ccc5oc6c(ccc7c8cc9ccccc9cc8oc76)c5c4)c3)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.41
PLA2G4A P47712 4/20 0.41
PLA2G10 O15496 1/20 0.41
ESR1 P03372 6/20 0.39
ESR2 Q92731 5/20 0.39
PTPRF P10586 4/20 0.35
PTPN2 P17706 4/20 0.35
PTPN1 P18031 4/20 0.35
ALOX5 P09917 1/20 0.35
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP1B1 Q16678 1/20 0.34
PRKDC P78527 1/20 0.34
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081422 0.96 ESR1 (0.42) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL19081522 0.93 ESR1 (0.40) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL19081512 0.93 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL21450750 0.92 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL16067690 0.92 PLA2G2A (0.45) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL19079938 0.91 CYP1A1 (0.40) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL16067687 0.91 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL16068035 0.91 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL19076327 0.90 ALOX5 (0.39) PLA2G2APLA2G4APLA2G10ESR1ESR2
SCHEMBL16067649 0.89 PLA2G2A (0.45) PLA2G2APLA2G4APLA2G10ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PLA2G2A 4330/4885PLA2G4A 4338/4885PLA2G10 4054/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PLA2G2A 4330/4885PLA2G4A 4338/4885PLA2G10 4054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.